Hiroyuki Yoda, PhD

Title(s)Specialist, Neurology
SchoolSchool of Medicine
Address1450 Third St, #220
San Francisco CA 94158
ORCID ORCID Icon0000-0002-5528-8940 Additional info
vCardDownload vCard

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. ALK upregulates POSTN and WNT signaling to drive neuroblastoma. Cell Rep. 2024 Mar 05; 43(3):113927. Huang M, Fang W, Farrel A, Li L, Chronopoulos A, Nasholm N, Cheng B, Zheng T, Yoda H, Barata MJ, Porras T, Miller ML, Zhen Q, Ghiglieri L, McHenry L, Wang L, Asgharzadeh S, Park J, Gustafson WC, Matthay KK, Maris JM, Weiss WA. PMID: 38451815.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma. Cancer Med. 2023 03; 12(5):5821-5832. Tsujimoto A, Matsuo N, Lai X, Inoue T, Yoda H, Lin J, Shinozaki Y, Watanabe T, Koshikawa N, Takatori A, Nagase H. PMID: 36262061; PMCID: PMC10028039.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    3. CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma. Neuro Oncol. 2022 06 01; 24(6):886-887. Yoda H, Weiss WA. PMID: 35090034; PMCID: PMC9159426.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides. PLoS One. 2021; 16(9):e0257718. Ota Y, Yoda H, Inoue T, Watanabe T, Shinozaki Y, Takatori A, Nagase H. PMID: 34591871; PMCID: PMC8483358.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    5. CD133 prevents colon cancer cell death induced by serum deprivation through activation of Akt-mediated protein synthesis and inhibition of apoptosis. FEBS Open Bio. 2021 05; 11(5):1382-1394. Mori Y, Takeuchi A, Miyagawa K, Yoda H, Soda H, Nabeya Y, Watanabe N, Ozaki T, Shimozato O. PMID: 33720534; PMCID: PMC8091590.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    6. An expanded universe of cancer targets. Cell. 2021 03 04; 184(5):1142-1155. Hahn WC, Bader JS, Braun TP, Califano A, Clemons PA, Druker BJ, Ewald AJ, Fu H, Jagu S, Kemp CJ, Kim W, Kuo CJ, McManus M, B Mills G, Mo X, Sahni N, Schreiber SL, Talamas JA, Tamayo P, Tyner JW, Wagner BK, Weiss WA, Gerhard DS, Cancer Target Discovery and Development Network. PMID: 33667368; PMCID: PMC8066437.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimals
    7. Targeting the mutant PIK3CA gene by DNA-alkylating pyrrole-imidazole polyamide in cervical cancer. Cancer Sci. 2021 Mar; 112(3):1141-1149. Krishnamurthy S, Yoda H, Hiraoka K, Inoue T, Lin J, Shinozaki Y, Watanabe T, Koshikawa N, Takatori A, Nagase H. PMID: 33377228; PMCID: PMC7935806.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    8. Vitamin K3 derivative induces apoptotic cell death in neuroblastoma via downregulation of MYCN expression. Biochem Biophys Rep. 2019 Dec; 20:100701. Yoda H, Nakayama T, Miura M, Toriyama M, Motohashi S, Suzuki T. PMID: 31844686; PMCID: PMC6895568.
      View in: PubMed   Mentions: 2  
    9. PTPRK suppresses progression and chemo-resistance of colon cancer cells via direct inhibition of pro-oncogenic CD133. FEBS Open Bio. 2019 05; 9(5):935-946. Matsushita M, Mori Y, Uchiumi K, Ogata T, Nakamura M, Yoda H, Soda H, Takiguchi N, Nabeya Y, Shimozato O, Ozaki T. PMID: 30947381; PMCID: PMC6487712.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    10. Estimating genome-wide off-target effects for pyrrole-imidazole polyamide binding by a pathway-based expression profiling approach. PLoS One. 2019; 14(4):e0215247. Lin J, Krishnamurthy S, Yoda H, Shinozaki Y, Watanabe T, Koshikawa N, Takatori A, Horton P, Nagase H. PMID: 30964912; PMCID: PMC6456183.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    11. Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma. Cancer Res. 2019 02 15; 79(4):830-840. Yoda H, Inoue T, Shinozaki Y, Lin J, Watanabe T, Koshikawa N, Takatori A, Nagase H. PMID: 30584073.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    12. Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63. PLoS One. 2017; 12(7):e0179884. Ogata T, Nakamura M, Sang M, Yoda H, Hiraoka K, Yin D, Sang M, Shimozato O, Ozaki T. PMID: 28671946; PMCID: PMC5495219.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    13. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63. Oncotarget. 2016 Nov 01; 7(44):71937-71950. Ozaki T, Nakamura M, Ogata T, Sang M, Yoda H, Hiraoka K, Sang M, Shimozato O. PMID: 27713122; PMCID: PMC5342134.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    14. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death. Oncogenesis. 2016 Jun 13; 5(6):e233. Nakamura M, Sugimoto H, Ogata T, Hiraoka K, Yoda H, Sang M, Sang M, Zhu Y, Yu M, Shimozato O, Ozaki T. PMID: 27294865; PMCID: PMC4945741.
      View in: PubMed   Mentions: 11  
    15. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Cell Death Discov. 2015; 1:15010. Sugimoto H, Nakamura M, Yoda H, Hiraoka K, Shinohara K, Sang M, Fujiwara K, Shimozato O, Nagase H, Ozaki T. PMID: 27551445; PMCID: PMC4981025.
      View in: PubMed   Mentions: 12  
    16. Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole-imidazole polyamide conjugate. Nat Commun. 2015 Apr 27; 6:6706. Hiraoka K, Inoue T, Taylor RD, Watanabe T, Koshikawa N, Yoda H, Shinohara K, Takatori A, Sugimoto H, Maru Y, Denda T, Fujiwara K, Balmain A, Ozaki T, Bando T, Sugiyama H, Nagase H. PMID: 25913614.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    17. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity. FEBS J. 2015 Jan; 282(1):114-28. Ozaki T, Sugimoto H, Nakamura M, Hiraoka K, Yoda H, Sang M, Fujiwara K, Nagase H. PMID: 25331851; PMCID: PMC4368372.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    18. Vitamin K3 analogs induce selective tumor cytotoxicity in neuroblastoma. Biol Pharm Bull. 2012; 35(4):617-23. Kitano T, Yoda H, Tabata K, Miura M, Toriyama M, Motohashi S, Suzuki T. PMID: 22466570.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    Hiroyuki's Networks
    Concepts (102)
    Derived automatically from this person's publications.
    Co-Authors (7)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department